期刊文献+

胰腺癌干细胞的研究进展 被引量:3

Recent Progress on Pancreatic Cancer Stem Cells
原文传递
导出
摘要 目的总结有关胰腺癌干细胞的研究进展并明确今后的研究方向。方法收集国内、外近年来有关胰腺癌干细胞的文献并进行综述。结果胰腺癌恶性程度高,早期诊断困难,缺乏有效治疗手段。近年来的研究发现,胰腺癌中存在异质性细胞,这些细胞具有干细胞的性质,该细胞亚群在胰腺癌的发生、增殖、转移和耐药中发挥重要作用,通常利用细胞表面的特异标志物来鉴别胰腺癌干细胞。另外,研究还发现,胰腺癌干细胞内的一些维持自我更新和转移的信号通道表达异常。结论针对干细胞的治疗是可行的,深入了解胰腺癌干细胞的生物学行为将为胰腺癌的诊断和治疗提供新的策略和手段。 Objective To review the recent advances in the pancreatic cancer stem cells field and identify the research trend in future.Methods Current literatures on pancreatic cancer stem cells were collected and reviewed.Results Pancreatic cancer was a highly lethal disease and was usually diagnosed at a late stage,for which there were few effective therapies.Emerging evidence had suggested that pancreatic cancer cells proposed a heterogeneous organization.A subpopulation of stem cell-like cells sustains tumor growth,propagation,metastasis,and resistance to standard chemotherapy.Cancer stem cells were identified based on their expression of different sets of cell surface markers and functional characteristics.Some important signaling pathways which maintain self-renewal and metastasis were upregulated in pancreatic cancer stem cells.Conclusions Current findings clearly suggest that specific elimination of cancer stem cells is possible and therapeutically relevant.An improved understanding of the biological behavior of such cells may lead to the development of novel diagnosis and treatment regimens for pancreatic cancer.
作者 王晓辉 李非
出处 《中国普外基础与临床杂志》 CAS 2011年第9期931-935,共5页 Chinese Journal of Bases and Clinics In General Surgery
关键词 胰腺癌 干细胞 标志物 转移 化疗耐药 Pancreatic cancer Stem cell Marker Metastasis Chemoresistance
  • 相关文献

参考文献3

二级参考文献92

  • 1朱军华,陶凯雄,王国斌.TNF-α对肝癌细胞VEGF和MMP-9表达的影响[J].中国普外基础与临床杂志,2005,12(4):384-389. 被引量:15
  • 2Hanahan D, Weinberg RA. The hallmarks of cancer [J]. Cell, 2000; 100(1): 57
  • 3D'Amour KA, Gage FH. Are somatic stem cells pluripotent or lineage-restrieted? [J]. Nat Med, 2002; 8(3):213
  • 4Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells [J]. Nature, 2004; 432(7015): 396
  • 5Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice [J]. Nature, 1994; 367(6464):645
  • 6Park CH, Bergsagel DE, McCulloch EA. Mouse rnyeloma tumor stem cells: a primary cell culture assay [J]. J Natl Cancer Inst, 1971, 46(2): 411
  • 7O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating turnout growth in immunodeficient mice [J]. Nature, 2006; 445(7123):106
  • 8Collins AT, Berry PA, Hyde C, et al. Prospective identifica tion of tumorigenic prostate cancer stem cells [J]. Cancer Res, 2005; 65(23) : 10946
  • 9Suetsugu A, Nagaki M, Aoki H, et al. Characterization of CD133^+ hepatocellular carcinoma cells as cancer stem/progenitor cells [J]. Biochem Biophys Res Commun, 2006, 351(4) 820
  • 10Yin S, Li J, Hu C, et al. CD133 positive hepatocellular carci noma cells possess high capacity for tumorigenicity[J]. Int J Cancer, 2007; 120(7):1444

共引文献78

同被引文献45

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部